Suppr超能文献

2009 年,美国符合“儿童疫苗计划”条件的 13-17 岁青少年的疫苗接种覆盖率。

Vaccination coverage among U.S. adolescents aged 13-17 years eligible for the Vaccines for Children program, 2009.

机构信息

Centers for Disease Control and Prevention, National Center for Immunization and Respiratory Diseases, Atlanta, GA 30333, USA.

出版信息

Public Health Rep. 2011 Jul-Aug;126 Suppl 2(Suppl 2):124-34. doi: 10.1177/00333549111260S214.

Abstract

OBJECTIVES

We compared (1) characteristics of adolescents who are and are not entitled to receive free vaccines from the Vaccines for Children (VFC) program and (2) vaccination coverage with meningococcal conjugate (MCV4), quadrivalent human papillomavirus (HPV4), and tetanus-diphtheria-acellular pertussis (Tdap) vaccines among VFC-eligible and non-VFC-eligible adolescents.

METHODS

We analyzed data from the 2009 National Immunization Survey-Teen, a nationally representative, random-digit-dialed survey of households with adolescents aged 13-17 years (n = 20,066). Differences in sociodemographic characteristics and provider-reported vaccination coverage were evaluated using t-tests.

RESULTS

Overall, 32.1% (+/- 1.2%) of adolescents were VFC-eligible. VFC-eligible adolescents were significantly less likely than non-VFC-eligible adolescents to be white and to live in suburban areas, and more likely to live in poverty and to have younger and less educated mothers. Nationally, coverage among non-VFC-eligible adolescents was 57.1% (+/-1.5%) for > or = 1 dose of Tdap, 55.4% (+/-1.5%) for > or = 1 dose of MCV4, and 43.2% (+/- 2.2%) for > or = 1 dose of HPV4. Coverage among VFC-eligible adolescents was 52.5% (+/- 2.4%) for > or = 1 dose of Tdap, 50.1% (+/- 2.4%) for > or = 1 dose of MCV4, and 46.6% (+/- 3.5%) for > or =1 dose of HPV4. Only 27.5% (+/- 1.8%) of non-VFC-eligible adolescents and 25.0% (+/- 2.9%) of VFC-eligible adolescents received > or = 3 doses of HPV4. Vaccination coverage was significantly higher among non-VFC-eligible adolescents for Tdap and MCV4, but not for one-dose or three-dose HPV4. Conclusions. Coverage with some recommended vaccines is lower among VFC-eligible adolescents compared with non-VFC-eligible adolescents. Continued monitoring of adolescent vaccination rates, particularly among VFC-eligible populations, is needed to ensure that all adolescents receive all routinely recommended vaccines.

摘要

目的

我们比较了(1)有资格和没有资格从儿童疫苗计划(VFC)获得免费疫苗的青少年的特征,以及(2)VFC 合格和不合格青少年接种脑膜炎球菌结合疫苗(MCV4)、四价人乳头瘤病毒疫苗(HPV4)和破伤风、白喉和无细胞百日咳疫苗(Tdap)的疫苗接种覆盖率。

方法

我们分析了 2009 年全国免疫调查-青少年的数据,这是一项针对 13-17 岁青少年家庭的全国代表性、随机数字拨号调查(n = 20,066)。使用 t 检验评估社会人口统计学特征和提供者报告的疫苗接种覆盖率差异。

结果

总体而言,32.1%(+/-1.2%)的青少年有资格参加 VFC。与非 VFC 合格青少年相比,VFC 合格青少年明显不太可能是白人,不太可能居住在郊区,更有可能生活在贫困中,母亲更年轻,教育程度更低。在全国范围内,非 VFC 合格青少年 Tdap 接种率为 57.1%(+/-1.5%),MCV4 接种率为 55.4%(+/-1.5%),HPV4 接种率为 43.2%(+/-2.2%)。VFC 合格青少年 Tdap 接种率为 52.5%(+/-2.4%),MCV4 接种率为 50.1%(+/-2.4%),HPV4 接种率为 46.6%(+/-3.5%)。只有 27.5%(+/-1.8%)的非 VFC 合格青少年和 25.0%(+/-2.9%)的 VFC 合格青少年接受了 3 剂 HPV4 疫苗。非 VFC 合格青少年的 Tdap 和 MCV4 疫苗接种覆盖率明显高于 VFC 合格青少年,但 HPV4 的一剂或三剂疫苗接种覆盖率并非如此。结论。与非 VFC 合格青少年相比,VFC 合格青少年的一些推荐疫苗接种覆盖率较低。需要继续监测青少年疫苗接种率,特别是 VFC 合格人群的疫苗接种率,以确保所有青少年都接种所有常规推荐的疫苗。

相似文献

1
Vaccination coverage among U.S. adolescents aged 13-17 years eligible for the Vaccines for Children program, 2009.
Public Health Rep. 2011 Jul-Aug;126 Suppl 2(Suppl 2):124-34. doi: 10.1177/00333549111260S214.
2
Vaccination coverage among U.S. children aged 19-35 months entitled by the Vaccines for Children program, 2009.
Public Health Rep. 2011 Jul-Aug;126 Suppl 2(Suppl 2):109-23. doi: 10.1177/00333549111260S213.
3
Using the North Dakota Immunization Information System to determine adolescent vaccination rates and uptake.
Public Health Rep. 2011 Jul-Aug;126 Suppl 2(Suppl 2):78-86. doi: 10.1177/00333549111260S210.
5
Vaccination coverage among adolescents aged 13-17 years - United States, 2007.
MMWR Morb Mortal Wkly Rep. 2008 Oct 10;57(40):1100-3.
7
Missed Vaccination Opportunities Among U.S. Adolescents by Area Characteristics.
Am J Prev Med. 2022 Apr;62(4):538-547. doi: 10.1016/j.amepre.2021.10.014. Epub 2022 Feb 3.
9
National Vaccination Coverage Among Adolescents Aged 13-17 Years - National Immunization Survey-Teen, United States, 2023.
MMWR Morb Mortal Wkly Rep. 2024 Aug 22;73(33):708-714. doi: 10.15585/mmwr.mm7333a1.
10

引用本文的文献

1
Human Papillomavirus Vaccine Impact on Cervical Precancers in a Low-Vaccination Population.
Am J Prev Med. 2022 Mar;62(3):395-403. doi: 10.1016/j.amepre.2021.08.017. Epub 2021 Oct 29.
2
Trends in anogenital wart incidence among Tennessee Medicaid enrollees, 2006-2014: The impact of human papillomavirus vaccination.
Papillomavirus Res. 2019 Jun;7:141-149. doi: 10.1016/j.pvr.2019.04.007. Epub 2019 Apr 10.
4
Examination of universal purchase programs as a driver of vaccine uptake among US States, 1995-2014.
Vaccine. 2018 Jun 27;36(28):4032-4038. doi: 10.1016/j.vaccine.2018.05.103.
5
Impact of Provider Recommendation on Tdap Vaccination of Adolescents Aged 13-17 Years.
Am J Prev Med. 2017 Sep;53(3):373-384. doi: 10.1016/j.amepre.2017.03.022. Epub 2017 May 8.
6
HPV vaccination coverage of teen girls: the influence of health care providers.
Vaccine. 2016 Mar 18;34(13):1604-1610. doi: 10.1016/j.vaccine.2016.01.061. Epub 2016 Feb 5.
7
HPV vaccination initiation after the routine-recommended ages of 11-12 in the United States.
Papillomavirus Res. 2016 Dec 1;2:11-16. doi: 10.1016/j.pvr.2015.12.001.
8
Geographic Factors and Human Papillomavirus (HPV) Vaccination Initiation among Adolescent Girls in the United States.
Cancer Epidemiol Biomarkers Prev. 2016 Feb;25(2):309-17. doi: 10.1158/1055-9965.EPI-15-0658. Epub 2016 Jan 14.
9
Reply.
Am J Obstet Gynecol. 2016 May;214(5):667-8. doi: 10.1016/j.ajog.2015.12.059. Epub 2016 Jan 6.
10
Preexisting Chronic Health Conditions and Health Insurance Status Associated With Vaccine Receipt Among Adolescents.
J Adolesc Health. 2016 Feb;58(2):148-53. doi: 10.1016/j.jadohealth.2015.10.009. Epub 2015 Dec 10.

本文引用的文献

1
Vaccination coverage among U.S. children aged 19-35 months entitled by the Vaccines for Children program, 2009.
Public Health Rep. 2011 Jul-Aug;126 Suppl 2(Suppl 2):109-23. doi: 10.1177/00333549111260S213.
3
Geographic disparity, area poverty, and human papillomavirus vaccination.
Am J Prev Med. 2010 May;38(5):525-33. doi: 10.1016/j.amepre.2010.01.018.
4
Meningococcal conjugate vaccination among adolescents aged 13-17 years, United States, 2007.
Vaccine. 2010 Mar 8;28(11):2350-5. doi: 10.1016/j.vaccine.2009.12.032. Epub 2009 Dec 29.
5
Financing the delivery of vaccines to children and adolescents: challenges to the current system.
Pediatrics. 2009 Dec;124 Suppl 5:S548-57. doi: 10.1542/peds.2009-1542O.
6
Underinsurance and adolescent immunization delivery in the United States.
Pediatrics. 2009 Dec;124 Suppl 5:S515-21. doi: 10.1542/peds.2009-1542K.
7
Underinsurance and pediatric immunization delivery in the United States.
Pediatrics. 2009 Dec;124 Suppl 5:S507-14. doi: 10.1542/peds.2009-1542J.
8
Health care utilization by adolescents on medicaid: implications for delivering vaccines.
Pediatrics. 2010 Jan;125(1):43-9. doi: 10.1542/peds.2009-1044. Epub 2009 Nov 30.
9
Availability of human papillomavirus vaccine at medical practices in an area with elevated rates of cervical cancer.
J Adolesc Health. 2009 Nov;45(5):438-44. doi: 10.1016/j.jadohealth.2009.05.013. Epub 2009 Jul 22.
10
Determining accurate vaccination coverage rates for adolescents: the National Immunization Survey-Teen 2006.
Public Health Rep. 2009 Sep-Oct;124(5):642-51. doi: 10.1177/003335490912400506.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验